ExpreS2ion Biotech

These events represent important opportunities to showcase ExpreS2ion’s innovative technology platform and exciting development pipeline to scientific and investment audiences. More details, including event registration information, are available on the Company’s website and via the links below. To arrange a meeting at these events, please contact us at partnering@expres2ionbio.com or  investor@expres2ionbio.com.

3-5 November 2025 | BIO-Europe
Vienna, Austria
ExpreS2ion will be represented by business development at BIO-Europe 2025, Europe’s premier biopharma partnering conference, held at the Vienna Congress and Convention Center from November 3–5, followed by digital partnering sessions November 11–12. Event details here.

13 November 2025 | 2025 Interim Report (Q3) Presentation
Virtual, 11:00 CET
CEO Bent Frandsen and CFO Keith Alexander will present ExpreS2ion’s Q3 results and pipeline updates at a live virtual event hosted by H.C. Andersen Capital/Inderes. The session includes a live Q&A and is free for all investors. Register here.

12-13 September 2025 | BioStock Investing in Life Science: From Seed to Success
Lund, Sweden (Presenting 13 September at 14:55 CET)
CEO Bent Frandsen will present ExpreS2ion on 13 November at 14:55 CET during BioStock’s annual life science investment forum. The event features key themes including Women’s Health, Pharma Partnering, and AI in Healthcare. Attendance is free but limited. Apply here.

Certified Adviser
Svensk Kapitalmarknadsgranskning AB